Elite in Non-Alcoholic Fatty Liver Disease

Vincent W. Wong

30-32 Ngan Shing Street, 
Sha Tin, NST, HK 
Elite in Non-Alcoholic Fatty Liver Disease
30-32 Ngan Shing Street, 
Sha Tin, NST, HK 
OverviewLocationsClinical Research

Overview

Vincent Wong practices in Sha Tin, Hong Kong Special Administrative Region. Mr. Wong is rated as an Elite expert by MediFind in the treatment of Non-Alcoholic Fatty Liver Disease. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Hepatitis B, Hepatitis, Liver Transplant, and Hepatectomy.

His clinical research consists of co-authoring 505 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 231 articles and participated in 1 clinical trial in the study of Non-Alcoholic Fatty Liver Disease.

Gender
Male

Locations

30-32 Ngan Shing Street, Sha Tin, NST, Hong Kong Special Administrative Region

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Identification of Fatty Liver With Advanced Fibrosis in Patients With Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages: A Randomized Controlled Trial
Identification of Fatty Liver With Advanced Fibrosis in Patients With Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages: A Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: August 09, 2024
Intervention Type: Diagnostic test
Study Phase: Not Applicable
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
A Phase 4, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Effect of Obeticholic Acid on Clinical Outcomes in Patients With Primary Biliary Cholangitis
Enrollment Status: Terminated
Publish Date: March 09, 2023
Intervention Type: Drug
Study Drug: Obeticholic Acid 
Study Phase: Phase 4
View 1 Less Clinical Trial

505 Total Publications

A cost-effectiveness evaluation framework for treatment for metabolic dysfunction-associated steatohepatitis: potential and concerns.
A cost-effectiveness evaluation framework for treatment for metabolic dysfunction-associated steatohepatitis: potential and concerns.
Journal: Clinical and molecular hepatology
Published: December 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Wong's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 14 Advanced Conditions
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile